Abstract
Clinical treatment of B-cell chronic lymphocytic leukemia (B-CLL) is limited by the progressive drug resistance and nonselectivity of most drugs towards malignant cells. Depsipeptides are present in certain bacteria and display potent antitumor activity. We have studied the effect of the novel cyclodepsipeptide AT514 (serratamolide) from Serratia marcescens on B-CLL cell viability. AT514 induced apoptosis of B-CLL cells from the 21 patients studied, as confirmed by Annexin-V binding and nuclei condensation, with an average IC50 of 13 μ M. AT514 was effective in those B-CLL cases resistant to fludarabine, but had no effect on normal PBL. AT514 preferentially activated the intrinsic apoptotic pathway, as evidenced by loss of mitochondrial membrane potential, release of cytochrome c and activation of caspase-9 and -3, but not of caspase-8. Importantly, AT514 interfered with phosphatidylinositol-3 kinase and protein kinase C survival signals since it increased the apoptotic effect of LY294002 and BisI inhibitors, and induced Akt dephosphorylation at Ser 473. AT514 also decreased NF-κB activity by dramatically reducing the levels of p65 in B-CLL. This was confirmed on functional assays using NF-κB-luc-transfected Raji cells and transgenic mice. Our results establish that AT514 induces apoptosis of primary B-CLL cells and could be useful for clinical treatment of this malignancy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kroft SH, Finn WG, Peterson LC . The pathology of the chronic lymphoid leukaemias. Blood Rev 1995; 9: 234–250.
Bannerji R, Byrd JC . Update on the biology of chronic lymphocytic leukemia. Curr Opin Oncol 1998; 12: 22–29.
Jewell AP . Role of apoptosis in the pathogenesis of B-cell chronic lymphocytic leukaemia. Br J Biomed Sci 2002; 59: 235–238.
Barragán M, Bellosillo B, Campas C, Colomer D, Pons G, Gil J . Involvement of protein kinase C and phosphatidyl-inositol 3-kinase pathways in the survival of chronic lymphocytic leukemia cells. Blood 2002; 99: 2969–2976.
Ringshausen I, Schneller F, Bogner C, Hipp S, Duyster J, Peschel C et al. Constitutively activated phosphatidyl-inositol 3-kinase (PI3-K) is involved in the effect of apoptosis in B-CLL: association with protein kinase Cδ. Blood 2002; 100: 3741–3748.
Cuní S, Pérez-Aciego P, Pérez-Chacón G, Vargas JA, Sánchez A, Martín-Saavedra FM et al. A sustained activation of PI3K/NF-κB pathway is critical for the survival of chronic lymphocytic leukemia B cells. Leukemia 2004; 18: 1391–1400.
Furman RR, Asgary Z, Mascarenhas JO, Liou HC, Schattner EJ . Modulation of NF-κB activity and apoptosis in chronic lymphocytic leukemia B cells. J Immunol 2000; 164: 2200–2206.
Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC . Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 1993; 82: 1820–1828.
Pepper C, Hoy T, Bentley DP . Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro and clinical drug resistance. Br J Cancer 1997; 76: 935–938.
Thomas A, El Rouby S, Reed JC, Krajewsky S, Silber R, Potmesil M et al. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 mutations and bcl-2/bax proteins in drug resistance. Oncogene 1996; 12: 1055–1062.
Schriever F, Huhn D . New directions in the diagnosis and treatment of chronic lymphocytic leukaemia. Drugs 2003; 63: 953–969.
Ballard CE, Yu H, Wang B . Recent developments in depsipeptide research. Curr Med Chem 2002; 9: 471–498.
Khan SB, Maududi T, Barton K, Ayers J, Alkan S . Analysis of histone deacetylase inhibitor, depsipeptide (FR901228), effect on multiple myeloma. Br J Haematol 2004; 125: 156–161.
Byrd JC, Shinn C, Ravi R, Willis CR, Waselenko JK, Flinn IW et al. Depsipeptide (FR901228): a novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells. Blood 1999; 94: 1401–1408.
Aron JL, Parthun MR, Marcucci G, Kitada S, Mone AP, Davis ME et al. Depsipeptide FR901228 induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein. Blood 2003; 102: 652–658.
Bar-Ness R, Avrahamy N, Matsuyama T, Rosenberg M . Increased cell surface hydrophobicity of a Serratia marcescens NS 38 mutant lacking wetting activity. J Bacteriol 1988; 170: 4361–4364.
Millet I, Phillips RJ, Sherwin RS, Ghosh S, Voll RE, Flavell RA et al. Inhibition of NF-κB activity and enhancement of apoptosis by the neuropeptide calcitonin gene-related peptide. J Biol Chem 2000; 275: 15114–15121.
Cohen GM . Caspases: the executioners of apoptosis. Biochem J 1997; 326: 1–16.
Kane LP, Shapiro VS, Stokoe D, Weiss A . Induction of NF-κB by the Akt/PKB kinase. Curr Biol 1999; 9: 601–604.
Madrid LV, Wang CY, Gurrtidge DC, Schottelius AJ, Baldwin Jr S, Mayo MW . Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-κB. Mol Cell Biol 2000; 20: 1626–1638.
Yano O, Kanellopoulos J, Kieran M, Le Bail O, Israel A, Kourilsky P . Purification of KBF1, a common factor binding to both H-2 and beta 2-microglobulin enhancers. EMBO J 1987; 6: 3317–3324.
Bellosillo B, Villamor N, Colomer D, Pons G, Montserrat E, Gil J . In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia. Blood 1999; 94: 2836–2843.
De la Fuente MT, Casanova B, Cantero E, Hernández del Cerro M, García-Marco J, Silva A et al. Involvement of p53 in α4β1 integrin-mediated resistance of B-CLL cells to fludarabine. Biochem Biophys Res Comm 2003; 311: 708–712.
Jones DT, Ganeshaguru K, Virchis AE, Folarin NI, Lowdell MW, Mehta AB et al. Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or γ radiation. Blood 2001; 98: 2800–2807.
Moon EY, Adam L . PDE4 inhibitors activate a mitochondrial apoptotic pathway in chronic lymphocytic leukemia cells that is regulated by protein phosphatase 2A. Blood 2003; 101: 4122–4130.
Decker T, Oelsner M, Kreitman RJ, Salvatore G, Wang Q-C, Pastan I et al. Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins. Blood 2004; 103: 2718–2726.
Campas C, López JM, Santidrián AF, Barragán M, Bellosillo B, Colomer D et al. Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytes. Blood 2003; 101: 3674–3680.
Lucas DM, Davis ME, Parthun MR, Mone AP, Kitada S, Cunningham KD et al. The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cells. Leukemia 2004; 18: 1207–1214.
Jones DT, Ganeshaguru K, Anderson RJ, Jackson TR, Bruckdorfer KR, Low SY et al. Albumin activates the Akt signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil-and radiation-induced apoptosis. Blood 2003; 101: 3174–3180.
Kandel ES, Hay N . The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res 1999; 253: 210–229.
Fecteau KA, Mei J, Wang H-CR . Differential modulation of signalling pathways and apoptosis of ras-transformed 10T1/2 cells by the depsipeptide FR901228. J Pharmacol Exp Ther 2002; 300: 890–899.
Burstein E, Duckett CS . Dying for NF-κB? Control of cell death by transcriptional regulation of the apoptotic machinery. Curr Opin Cell Biol 2003; 15: 732–737.
Dewson G, Snowden RT, Almond JB, Dyer MJS, Cohen GM . Conformational change and mitochondrial translocation of Bax accompany proteasome inhibitor-induced apoptosis of chronic lymphocytic leukemic cells. Oncogene 2003; 22: 2643–2654.
Yamaguchi H, Wang HG . The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene 2001; 20: 7779–7786.
Tsuruta F, Masuyama N, Gotoh Y . The phosphatidylinositol 3-kinase (PI3-K)-Akt pathway suppresses Bax translocation to mitochondria. J Biol Chem 2002; 277: 14040–14047.
Senderowicz AM . Targeting cell cycle and apoptosis for the treatment of human malignancies. Curr Opin Cell Biol 2004; 16: 670–678.
Acknowledgements
We thank the B-CLL patients who donated blood samples for this research and Dr Maria José Terol (Hospital Clínico, Valencia, Spain) for providing some of these samples. Drs Angel Corbí and José L Rodríguez-Fernández for valuable help and advice with the NF-κB studies and for reviewing the manuscript, and Dr Pedro Lastres for help with the flow cytometry analyses. This work was supported by grants 08.3/0030.1/2003 from the Comunidad Autónoma de Madrid, SAF2003-00824 from the Ministerio de Ciencia y Tecnología (MCyT), and 01/1183 from Fondo de Investigación Sanitaria (to AGP); and CIDEM Grant 301888 (Generalitat de Catalunya)/Fundació Bosch i Gimpera, to RPT). E Escobar and E López-Martín were supported by fellowships from MCyT.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu).
Rights and permissions
About this article
Cite this article
Escobar-Díaz, E., López-Martín, E., Hernández del Cerro, M. et al. AT514, a cyclic depsipeptide from Serratia marcescens, induces apoptosis of B-chronic lymphocytic leukemia cells: interference with the Akt/NF-κB survival pathway. Leukemia 19, 572–579 (2005). https://doi.org/10.1038/sj.leu.2403679
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403679
Keywords
This article is cited by
-
Biocontrol capabilities of the genus Serratia
Phytochemistry Reviews (2020)
-
Biosurfactants produced by Serratia species: Classification, biosynthesis, production and application
Applied Microbiology and Biotechnology (2019)
-
The infection of Harmonia axyridis by a parasitic nematode is mediated by entomopathogenic bacteria and triggers sex-specific host immune responses
Scientific Reports (2018)
-
Down-regulation of the PI3K/Akt signaling pathway and induction of apoptosis in CA46 Burkitt lymphoma cells by baicalin
Journal of Experimental & Clinical Cancer Research (2012)
-
Targeting NF-κB in hematologic malignancies
Cell Death & Differentiation (2006)